Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study

Yurdaydın, CihanWedemeyer, HeinerCaruntu, Florin A.Curescu, Manuela G.Yalçın, KendalAkarca, Ulus S.Zeuzem, StefanErhardt, AndreasLueth, StefanPapatheodoridis, George V.Port, KerstinKeskin, OnurRadu, Monica N.Çelen, Mustafa K.İdilman, RamazanStift, JudithMederacke, IngmarHeidrich, BenjaminManns, Michael P.Dienes, Hans Peter2022-09-292022-09-292012-10Yurdaydın, C. vd. (2012). "Pegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 study". Hepatology, 56, Supplement 1, 202A-203A.0270-9139https://aasldpubs.onlinelibrary.wiley.com/loi/15273350/year/2012http://hdl.handle.net/11452/28877Bu çalışma, 9-13 Kasım 2012 tarihleri arasında Boston[ABD]'da düzenlenen 63. Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)'de bildiri olarak sunulmuştur.eninfo:eu-repo/semantics/closedAccessGastroenterology & hepatologyPegylated-Interferon-a-2a plus Tenofovir or Placebo for the treatment of hepatitis delta: First results of the HIDIT-2 studyMeeting Abstract000310955601024202A203A56Supplement 1Gastroenterology & hepatology